| 3.59 -0.98 (-21.44%) | 07-30 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 6.38 |
1-year : | 8.56 |
| Resists | First : | 5.46 |
Second : | 7.33 |
| Pivot price | 4.3 |
|||
| Supports | First : | 2.44 | Second : | 2.03 |
| MAs | MA(5) : | 3.32 |
MA(20) : | 4.86 |
| MA(100) : | 7.4 |
MA(250) : | 13.52 |
|
| MACD | MACD : | -1 |
Signal : | -1 |
| %K %D | K(14,3) : | 25.1 |
D(3) : | 15.7 |
| RSI | RSI(14): 37.3 |
|||
| 52-week | High : | 32.54 | Low : | 2.44 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AMIX ] has closed above bottom band by 33.1%. Bollinger Bands are 88.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 4.38 - 4.41 | 4.41 - 4.43 |
| Low: | 3.31 - 3.34 | 3.34 - 3.36 |
| Close: | 3.55 - 3.59 | 3.59 - 3.63 |
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Wed, 29 Jul 2026
Autonomix Medical (AMIX) surges as traders react to recent renal-study data and fresh patent updates - Quiver Quantitative
Wed, 29 Jul 2026
Autonomix Medical, Inc. (NASDAQ:AMIX) rises as cash-per-share differential aligns with warrant overhang - TechStock²
Wed, 29 Jul 2026
Autonomix Medical (AMIX) Stock Rallies Over 54% After Hours: Here's Why - Benzinga
Tue, 28 Jul 2026
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Mon, 27 Jul 2026
Autonomix Medical Inc (AMIX) Institutional Confidence - TradingKey
Fri, 24 Jul 2026
AMIX Drops As Warrant Inducement Raises Dilution Fears - StocksToTrade
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 4.1 (%) |
| Held by Institutions | 4.2 (%) |
| Shares Short | 62 (K) |
| Shares Short P.Month | 16 (K) |
| EPS | -48.73 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.85 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -122.4 % |
| Return on Equity (ttm) | -238.9 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -31.35 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.08 |
| PEG Ratio | 0 |
| Price to Book value | 0.33 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.16 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |